Literature DB >> 26109588

Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size.

Juefei Wu1, Feng Xie2, John Lof2, Samer Sayyed2, Thomas R Porter2.   

Abstract

OBJECTIVE: We sought to determine whether guided high mechanical index (MI) impulses from a diagnostic ultrasound transducer during an intravenous microbubble infusion could augment low-dose fibrinolytic therapy in treating acute myocardial infarction (ST segment elevation myocardial infarction, STEMI).
METHODS: Acute thrombotic occlusions of the left anterior descending were created in 32 atherosclerotic pigs. Fourteen historical control pigs received half dose of tissue plasminogen activator alone (half tPA), while the subsequent 18 were randomised to (a) 1.0 mg/kg tPA (full-dose tPA); (b) low-dose tPA (0.5 mg/kg) and an intravenous microbubble infusion where guided transthoracic high MI impulses were applied intermittently to the risk area (guided high MI/half tPA) or (c) guided high MI impulses and microbubbles alone (guided high MI alone). Angiographic recanalisation, ST segment resolution and wall thickening (WT) at 60 min were compared between all pigs, while indexed infarct size at 48 h was compared in the 18 randomised pigs.
RESULTS: Recanalisation rates improved from 36% for half dose tPA alone to 83% with the addition of guided high MI impulses, while it was 50% for full-dose tPA and guided high MI alone. WT recovery within the risk area following treatment was highest for guided high MI/half tPA (p=0.007 compared with full-dose tPA; ANOVA), and indexed infarct size was lowest (p<0.05 compared to full-dose tPA).
CONCLUSIONS: Guided high MI-induced microbubble cavitation from a diagnostic transducer added to low-dose tPA can immediately improve regional function and reduce infarct size in acute STEMI. TRIAL REGISTRATION NUMBER: Clinical Trials.gov NCT02170103. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  CARDIAC PROCEDURES AND THERAPY

Mesh:

Substances:

Year:  2015        PMID: 26109588     DOI: 10.1136/heartjnl-2015-307625

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

Review 1.  A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis.

Authors:  Yadong Shi; Wanyin Shi; Liang Chen; Jianping Gu
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

2.  Targeted Transthoracic Acoustic Activation of Systemically Administered Nanodroplets to Detect Myocardial Perfusion Abnormalities.

Authors:  Thomas R Porter; Christopher Arena; Samer Sayyed; John Lof; Robin R High; Feng Xie; Paul A Dayton
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

Review 3.  Cardiovascular Sonothrombolysis.

Authors:  Thomas R Porter; Wilson Mathias
Journal:  Curr Cardiol Rep       Date:  2019-07-25       Impact factor: 2.931

4.  Guided longer pulses from a diagnostic ultrasound and intraclot microbubble enhanced catheter-directed thrombolysis in vivo.

Authors:  Shunji Gao; Qiong Zhu; Xiaoxiao Dong; Zhong Chen; Zheng Liu; Feng Xie
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

5.  Artificial intelligence and guidance of medicine in the bubble.

Authors:  Asma Akbar; Nagavalli Pillalamarri; Sriya Jonnakuti; Mujib Ullah
Journal:  Cell Biosci       Date:  2021-06-09       Impact factor: 7.133

Review 6.  De novo Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions.

Authors:  Syed Baseeruddin Alvi; Salmman Ahmed; Divya Sridharan; Zahra Naseer; Nooruddin Pracha; Henry Wang; Konstantinos Dean Boudoulas; Wuqiang Zhu; Nazish Sayed; Mahmood Khan
Journal:  Front Cardiovasc Med       Date:  2021-09-28

7.  Quantification of microbubble-induced sonothrombolysis in an ex vivo non-human primate model.

Authors:  Monica T Hinds; Azzdine Y Ammi; Jennifer Johnson; Sanjiv Kaul
Journal:  J Thromb Haemost       Date:  2020-12-23       Impact factor: 5.824

Review 8.  Utilization of diagnostic ultrasound and intravenous lipid-encapsulated perfluorocarbons in non-invasive targeted cardiovascular therapeutics.

Authors:  Thomas R Porter; Songita A Choudhury; Feng Xie
Journal:  J Ther Ultrasound       Date:  2016-07-15

9.  Diagnostic Ultrasound and Microbubbles Treatment Improves Outcomes of Coronary No-Reflow in Canine Models by Sonothrombolysis.

Authors:  Hairui Li; Yongkang Lu; Yili Sun; Gangbin Chen; Junfen Wang; Shifei Wang; Chixiong Huang; Lintao Zhong; Xiaoyun Si; Wangjun Liao; Yulin Liao; Shiping Cao; Jianping Bin
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.